India Immunoassay Testing Market Size & Growth Rate
According to 6Wresearch internal database and industry insights, the India Immunoassay Testing Market was valued at USD 132.0 million in 2025 and is projected to reach USD 195.87 million by 2032, growing at a CAGR of approximately 5.8% during 2026–2032.
India Immunoassay Testing Market Highlights
| Report Metric | Details |
| Report Name | India Immunoassay Testing Market |
| Market Size 2025 | USD 132.0 million |
| Market Size 2032 | USD 195.87 million |
| Absolute Growth 2025–2032 | USD 63.87 million |
| CAGR 2026–2032 | 5.8% |
| Peak Annual Growth | 8.0% in 2032 |
| Forecast Period | 2026–2032 |
| Historical Data | 2022–2025 |
| Base Year | 2025 |
| Leading Test Type, 2025 | Antibody Testing (45% share) |
| Leading Sample Type, 2025 | Blood (36% share) |
| Leading Disease Focus, 2025 | COVID-19 (30% share) |
| Leading End User, 2025 | Hospitals (39% share) |
| Fastest-Growing Test Type | Hormone Assays (8.2% CAGR) |
| Fastest-Growing Sample Type | Serum (7.4% CAGR) |
| Fastest-Growing Disease Focus | Thyroid (7.4% CAGR) |
| Fastest-Growing End User | Endocrinology Clinics (7.2% CAGR) |
| Growing Sector | Endocrinology Clinics |
| Key End Users | Hospitals, Diagnostic Labs, Endocrinology Clinics, Oncology Centers |
India Immunoassay Testing Market Year-wise Growth Rate and Key Drivers (2022–2032)
This graph illustrates the annual growth rates of the market from 2022 to 2032, highlighting a steady upward trajectory and projected market expansion over the forecast period.
Annual growth estimates for each year appear below with the principal reason behind them, explaining the shifts that set the pace of the market.
| Year | Estimated Annual Growth (%) | Market Rationale |
| 2022 | 6.7 | The market experienced steady demand from diagnostic labs and hospitals. |
| 2023 | 3.7 | Growth slowed due to temporary supply chain disruptions affecting testing capabilities. |
| 2024 | 5.6 | Demand increased as hospitals expanded their immunoassay testing services. |
| 2025 | 6.9 | Growth accelerated with rising awareness of disease detection among the population. |
| 2026 | 5.9 | The market is expected to see a slowdown as hospitals face budget constraints on new technologies. |
| 2027 | 7.8 | Demand will rise as more endocrinology clinics adopt immunoassay testing methods. |
| 2028 | 4.6 | Growth is projected to decelerate due to market saturation in urban areas. |
| 2029 | 5.2 | Increased cancer detection initiatives will boost demand for tumor marker tests. |
| 2030 | 4.1 | Growth is expected to slow as hospitals focus on cost-cutting measures amid economic pressures. |
| 2031 | 5.1 | Demand will increase with the introduction of new immunoassay technologies. |
| 2032 | 8.0 | The market will peak as the government expands funding for diagnostic services. |
Note: Market size estimations and growth projections presented in this report are based on 6Wresearch's proprietary forecasting methodology, utilizing the latest available industry data, government publications, and primary research inputs.
India Immunoassay Testing Market Synopsis
Immunoassay Testing in India encompasses biochemical tests that detect antibodies or antigens in samples. This testing is crucial for diagnosing diseases, monitoring health conditions, and conducting research. The India Immunoassay Testing Market is growing, driven by a population of approximately 1.4 billion, which increases the demand for testing services. Major buyer groups include hospitals and diagnostic labs, with initiatives from the National Health Mission and rising disease prevalence contributing to this market expansion.
Market Dynamics Impact Analysis (2026–2032)
| Factor | Type | Impact | Primary Segment Affected |
| Rising prevalence of chronic diseases increases demand for immunoassay testing. | Driver | High | Tumor Marker Tests |
| Growing number of diagnostic labs improves access to immunoassay testing. | Driver | High | Diagnostic Labs |
| Investment in diagnostic infrastructure opens new market opportunities. | Opportunity | High | Diagnostic Labs |
| Increasing focus on early disease detection drives demand for immunoassays. | Opportunity | Medium | HIV |
| Budget constraints limit hospitals' ability to invest in new technologies. | Restraint | High | Hospitals |
| Limited awareness of immunoassay testing in rural areas hampers growth. | Restraint | Medium | Diagnostic Labs |
| Supply chain disruptions can affect the availability of reagents. | Challenge | High | Diagnostic Labs |
| Competition from alternative testing methods can limit market share. | Challenge | Medium | Antigen Testing |
Evaluation of Drivers in India Immunoassay Testing Market (2026–2032)
Key forces behind demand, with the segment each one moves most, are listed below.
| Drivers | Primary Segment Affected | Why It Matters (Evidence) |
| Growing prevalence of thyroid disorders increases testing demand. | Thyroid | Around 42 million people in India are affected, prompting hospitals to increase testing. |
| Expansion of diagnostic labs improves access to immunoassay testing. | Diagnostic Labs | India has over 1,500 diagnostic labs, facilitating more widespread testing. |
| Government initiatives boost funding for diagnostic services. | Diagnostic Labs | The government allocated funds to improve diagnostic infrastructure in rural areas. |
| Rising cancer cases necessitate more tumor marker tests. | Tumor Marker Tests | Cancer detection tests are critical as cancer cases are rising in India. |
| Increased awareness of health monitoring drives hormone assay demand. | Hormone Assays | Endocrinology clinics are increasingly adopting immunoassay technologies for patient care. |
Market growth for Immunoassay Testing in India is underpinned by rising end-use demand from hospitals and diagnostic labs, alongside an expanding supply response from the healthcare sector. The increasing prevalence of thyroid disorders, affecting around 42 million people, drives hospitals to enhance testing capabilities. With over 1,500 diagnostic labs available, access to immunoassay testing is improving across the country. Rising cancer cases necessitate more tumor marker tests, while increased awareness of health monitoring drives demand for hormone assays in endocrinology clinics.
Evaluation of Restraints in India Immunoassay Testing Market
Below mentioned are some major restraints and their influence on market dynamics.
| Market Restraint | Primary Segment Affected | Why It Matters (Evidence) |
| Budget constraints limit hospitals' ability to invest in new technologies. | Hospitals | Many hospitals face financial limitations, restricting their procurement of advanced testing equipment. |
| Limited awareness of immunoassay testing in rural areas hampers growth. | Diagnostic Labs | Rural populations may not fully understand the benefits of immunoassay testing. |
| Regulatory hurdles can delay the approval of new testing methods. | Diagnostic Labs | Complex approval processes slow down the introduction of new immunoassay technologies. |
| Supply chain disruptions can affect the availability of reagents. | Diagnostic Labs | Global supply chain issues have impacted the timely delivery of essential testing materials. |
| Competition from alternative testing methods can limit market share. | Antigen Testing | Emerging technologies may provide faster results, affecting immunoassay demand. |
India Immunoassay Testing Market Challenges
Buyers and suppliers in the India immunoassay testing market face supply chain disruptions due to the limited availability of specific reagents, which can delay testing processes for diagnostic labs. Rising costs of raw materials have increased operational expenses, forcing hospitals to allocate up to 15% more of their budgets for immunoassay testing. A shortage of skilled laboratory personnel hinders the effective implementation of advanced testing technologies, impacting the quality of services provided to patients. Outdated technology in some facilities can lead to inefficiencies, causing longer turnaround times for test results and affecting patient care across the healthcare system.
Trends in the India Immunoassay Testing Market
Buyers and suppliers in the India Immunoassay Testing Market are adjusting to the following trends.
- National Health Mission Strengthening Diagnostic Services: The National Health Mission launched the 'Strengthening of Diagnostic Services' programme in 2021, improving access to immunoassay testing. This initiative aims to enhance testing capabilities across India, benefiting millions.
- Increase in Cancer Detection Initiatives: In 2023, the government announced a scheme to improve diagnostic services in tier-2 cities, focusing on cancer detection. This initiative aims to address rising cancer cases, improving early diagnosis rates.
- Growth of Endocrinology Clinics: Endocrinology clinics are increasingly adopting immunoassay technologies for patient care, with a projected growth rate of 7.2%. This shift reflects the rising demand for hormone testing in India.
- Focus on Thyroid Testing: Thyroid disorders affect around 42 million people in India, driving demand for related immunoassay tests. The emphasis on thyroid testing is expected to grow, influencing market dynamics.
Investment Opportunities in the India Immunoassay Testing Market
Several openings in the India Immunoassay Testing Market merit attention from investors.
- Government Funding for Diagnostic Infrastructure: The Indian government allocated USD 50 million for improving diagnostic infrastructure, focusing on rural areas. This presents an opportunity for suppliers to invest in diagnostic labs and services.
- Expansion of Endocrinology Clinics: With a growing focus on hormone health, endocrinology clinics are increasingly adopting immunoassay technologies. This trend opens avenues for suppliers to partner with clinics for advanced testing solutions.
- Growing Need for Cancer Detection: The increasing number of cancer cases creates an opportunity for tumor marker tests. Suppliers can target oncology centres to meet the growing testing needs.
- Government Schemes Supporting Diagnostic Services: The government's 'Diagnostic Infrastructure Improvement Scheme' supports funding for diagnostic labs. This initiative encourages partnerships with local players to improve service delivery.
Government Initiatives in the India Immunoassay Testing Market
The National Health Mission launched the 'Strengthening of Diagnostic Services' programme in 2021, aiming to enhance testing capabilities across India. This initiative has resulted in improved access to immunoassay testing, particularly in underserved regions. In 2022, the Ministry of Health and Family Welfare introduced the 'National Viral Hepatitis Control Programme' to enhance hepatitis testing and treatment access, further supporting the immunoassay sector. The updated 'National AIDS Control Programme' in 2021 expanded access to HIV immunoassay testing, ensuring timely diagnosis and treatment for affected individuals. These measures aim to improve the diagnostic infrastructure, addressing the growing healthcare needs of the population.
In 2023, the government announced the 'Diagnostic Infrastructure Improvement Scheme' to fund diagnostic labs in underserved regions, with an allocation of USD 50 million. The scheme, administered by the Ministry of Health and Family Welfare, focuses on enhancing laboratory capabilities to facilitate immunoassay testing. Additionally, the Indian Council of Medical Research plays a crucial role in approving research projects aimed at advancing immunoassay technologies, ensuring that diagnostic practices meet international standards. These initiatives are important for improving healthcare delivery and expanding the reach of immunoassay testing across the country.
Future Insight of the India Immunoassay Testing Market
The India immunoassay testing market will undergo notable changes by 2032, primarily through advancements in diagnostic technology, particularly with automated testing systems. The government’s initiative to enhance diagnostic services in tier-2 cities will expand access to immunoassay testing for a larger population, potentially reaching over 200 million individuals. Research support from the Indian Council of Medical Research will drive innovation in immunoassay technologies, improving accuracy and efficiency in disease detection. The adoption of ISO 15189 standards will elevate the quality of laboratory practices, benefiting both buyers and suppliers.
Market Segmentation Analysis
Each segment group is reviewed below, with the leader by share and the fastest grower by CAGR.
By Test Type – Antibody Testing Dominated, Hormone Assays Expected to Grow Fastest
According to Sachin Kumar Rai, Senior Research Analyst at 6Wresearch, in 2025, Antibody Testing led the test type split with a 45% share. Antibody Testing holds the largest share as it is extensively used for detecting specific antibodies in blood samples, particularly in hospitals and diagnostic labs. The endorsement of antibody tests by health initiatives has significantly boosted their adoption across India. The quickest growth will come from Hormone Assays, forecast to expand at a CAGR of 8.2% between 2026 and 2032. Hormone Assays are rapidly growing due to their critical role in measuring hormone levels, especially in endocrinology clinics. The increasing prevalence of thyroid disorders, affecting around 42 million people in India, is a key factor driving this demand. Suppliers should focus on developing advanced hormone assay technologies to capture the growing market share.
By Sample Type – Blood Dominated, Serum Expected to Grow Fastest
Blood took a 36% share of sample type in 2025, more than any other category. Blood is the primary sample type for immunoassay tests, accounting for the largest share due to its effectiveness in various diagnostic applications. With over 1,500 diagnostic labs in India, blood samples are extensively utilised for testing, ensuring a strong market presence. Over 2026–2032, Serum is expected to post the fastest growth, at a CAGR of 7.4%. Serum is the fastest-growing sample type, commonly used in diagnostics for its reliability in immunoassay testing. The increasing number of hospitals equipped with immunoassay facilities is significantly driving this trend. Buyers should ensure access to high-quality serum testing capabilities to meet the rising demand.
By Disease Focus – COVID-19 Dominated, Thyroid Expected to Grow Fastest
The largest disease focus category in 2025 was COVID-19, with a 30% share of total revenue. COVID-19 testing has the largest share in the market, driven by the urgent need for diagnostics during the pandemic. The significant focus on COVID-19 has led to increased investments in testing infrastructure across India, solidifying its market position. Thyroid is projected to grow fastest, at a CAGR of 7.4% during 2026–2032. Thyroid testing is growing rapidly due to the rising incidence of thyroid disorders, with 42 million affected individuals in India. This surge in awareness and diagnosis is propelling the demand for thyroid-related immunoassays, further expanding this segment. Suppliers should prioritise the development of thyroid testing solutions to capitalise on this expanding market segment.
By End User – Hospitals Dominated, Endocrinology Clinics Expected to Grow Fastest
Hospitals held a 39% share of the India Immunoassay Testing Market by end user in 2025. Hospitals are the leading end user of immunoassay testing, utilising these tests for a wide range of diagnostic purposes. With a robust network of over 500 hospitals equipped with immunoassay facilities, their substantial market share reflects their critical role in healthcare. Endocrinology Clinics are set to record the highest CAGR in this split, 7.2% over 2026–2032. Endocrinology Clinics are witnessing the fastest growth as they increasingly adopt immunoassays for hormone testing. The rising number of clinics focusing on endocrine health is significantly driving this segment's expansion, indicating a shift in healthcare priorities. Suppliers should target endocrinology clinics with tailored solutions to leverage this growth opportunity.
Key Attractiveness of the Report
- 10 Years of Market Numbers
- Historical Data Starting from 2022 to 2025
- Base Year 2025
- Forecast Data until 2032
- Key Performance Indicators Impacting the Market
- Major Upcoming Developments and Projects
Key Highlights of the Report:
- India Immunoassay Testing Market Outlook
- Market Size of India Immunoassay Testing Market, 2025
- Forecast of India Immunoassay Testing Market, 2032
- Historical Data and Forecast of India Immunoassay Testing Revenues & Volume for the Period 2022 - 2032F
- India Immunoassay Testing Market Trend Evolution
- India Immunoassay Testing Market Drivers and Challenges
- India Immunoassay Testing Price Trends
- India Immunoassay Testing Porter's Five Forces
- India Immunoassay Testing Industry Life Cycle
- Historical Data and Forecast of India Immunoassay Testing Market Revenues & Volume By Test Type for the Period 2022 - 2032F
- Historical Data and Forecast of India Immunoassay Testing Market Revenues & Volume By Antibody Testing for the Period 2022 - 2032F
- Historical Data and Forecast of India Immunoassay Testing Market Revenues & Volume By Antigen Testing for the Period 2022 - 2032F
- Historical Data and Forecast of India Immunoassay Testing Market Revenues & Volume By Hormone Assays for the Period 2022 - 2032F
- Historical Data and Forecast of India Immunoassay Testing Market Revenues & Volume By Tumor Marker Tests for the Period 2022 - 2032F
- Historical Data and Forecast of India Immunoassay Testing Market Revenues & Volume By Sample Type for the Period 2022 - 2032F
- Historical Data and Forecast of India Immunoassay Testing Market Revenues & Volume By Blood, Serum for the Period 2022 - 2032F
- Historical Data and Forecast of India Immunoassay Testing Market Revenues & Volume By Swab, Blood for the Period 2022 - 2032F
- Historical Data and Forecast of India Immunoassay Testing Market Revenues & Volume By Blood, Saliva for the Period 2022 - 2032F
- Historical Data and Forecast of India Immunoassay Testing Market Revenues & Volume By Serum for the Period 2022 - 2032F
- Historical Data and Forecast of India Immunoassay Testing Market Revenues & Volume By Disease Focus for the Period 2022 - 2032F
- Historical Data and Forecast of India Immunoassay Testing Market Revenues & Volume By COVID-19, HIV for the Period 2022 - 2032F
- Historical Data and Forecast of India Immunoassay Testing Market Revenues & Volume By Influenza, Hepatitis for the Period 2022 - 2032F
- Historical Data and Forecast of India Immunoassay Testing Market Revenues & Volume By Thyroid, Reproductive for the Period 2022 - 2032F
- Historical Data and Forecast of India Immunoassay Testing Market Revenues & Volume By Cancer Detection for the Period 2022 - 2032F
- Historical Data and Forecast of India Immunoassay Testing Market Revenues & Volume By End User for the Period 2022 - 2032F
- Historical Data and Forecast of India Immunoassay Testing Market Revenues & Volume By Hospitals for the Period 2022 - 2032F
- Historical Data and Forecast of India Immunoassay Testing Market Revenues & Volume By Diagnostic Labs for the Period 2022 - 2032F
- Historical Data and Forecast of India Immunoassay Testing Market Revenues & Volume By Endocrinology Clinics for the Period 2022 - 2032F
- Historical Data and Forecast of India Immunoassay Testing Market Revenues & Volume By Oncology Centers for the Period 2022 - 2032F
- India Immunoassay Testing Import Export Trade Statistics
- Market Opportunity Assessment By Test Type
- Market Opportunity Assessment By Sample Type
- Market Opportunity Assessment By Disease Focus
- Market Opportunity Assessment By End User
- India Immunoassay Testing Top Companies Market Share
- India Immunoassay Testing Competitive Benchmarking By Technical and Operational Parameters
- India Immunoassay Testing Company Profiles
- India Immunoassay Testing Key Strategic Recommendations
Market Covered
Segments analysed in this report are listed below.
By Test Type
- Antibody Testing
- Antigen Testing
- Hormone Assays
- Tumor Marker Tests
By Sample Type
- Blood
- Serum
- Swab
- Saliva
By Disease Focus
- COVID-19
- HIV
- Influenza
- Hepatitis
- Thyroid
- Reproductive
- Cancer Detection
By End User
- Hospitals
- Diagnostic Labs
- Endocrinology Clinics
- Oncology Centers
